New Products

PLANO, Texas —  Lay's will roll out Lay's Wavy Potato Chips Dipped in Milk Chocolate next week, according to a report from USA Today.

BRYAN, Ohio, — This holiday season Spangler Candy Co. will launch limited-edition, holiday flavors in two of its most iconic brands: Dum Dums Holiday Pops and Peppermint Marshmallow Circus Peanuts, the company announced.

NEW YORK — The Food and Drug Administration has released a new video that warns consumers against buying drugs from rogue-internet pharmacies, part of the ongoing effort by the agency to keep fake and contaminated drugs out of the U.S. supply chain.

PITTSBURGH — Mylan expects to be the first to market with a generic version of a drug for treating patients with gout, the company said Friday, though its filing has triggered a lawsuit from the makers of the branded version.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for leukemia made by Genentech, the agency said Friday.

The FDA announced the approval of Gazyva (obinutuzumab) for treating patients with previously untreated chronic lymphocytic leukemia, in combination with the chemotherapy drug chlorambucil. The drug works by helping certain cells in the immune system attack cancer cells.

PLAINSBORO, N.J. — The Food and Drug Administration has approved two new insulin pens made by Novo Nordisk, the Danish drug maker said Friday.

Novo Nordisk announced the FDA approval of Novolog FlexTouch (insulin aspart [rDNA origin]) and Levemir FlexTouch (insulin detemir [rDNA origin]).

EVANSTON, Ill. — Kerrygold has announced that Dubliner cheese will now be available in convenient cracker-size slices.

Dubliner Cracker Cut Cheese, available at supermarkets nationwide, will come in a 6-ounce re-sealable parchment package, with 18 slices to a package. The pre-sliced cheese will measure 2x2 inches. This latest product will join Dubliner Cheese, Reduced Fat Dubliner Cheese and Dubliner with Irish Stout.

DUBLIN — Actavis is seeking Food and Drug Administration approval for a generic drug used to treat acne, triggering a lawsuit in a federal court from the maker of the branded version, the company said Thursday.

The drug maker said it had filed with the FDA for approval of isotretinoin capsules in the 10-mg, 20-mg, 30-mg and 40-mg strengths. The drug is a generic version of Ranbaxy's Absorica, a retinoid used to treat severe, recalcitrant nodular acne in patients 12 and older.